rs61753238
From SNPedia
| Orientation | plus |
| Stabilized | plus |
| Geno | Mag | Summary |
|---|---|---|
| (C;C) | 0 | common in clinvar |
| (C;G) | 3 | carrier of one Rhizomelic Chondrodysplasia Punctata Type I disorder allele |
| (G;G) | 7 | Rhizomelic Chondrodysplasia Punctata Type I disorder |
| Reference | GRCh38 38.1/141 |
| Chromosome | 6 |
| Position | 136822785 |
| Gene | PEX7 |
| is a | snp |
| is | mentioned by |
| dbSNP | rs61753238 |
| dbSNP (classic) | rs61753238 |
| ClinGen | rs61753238 |
| ebi | rs61753238 |
| HLI | rs61753238 |
| Exac | rs61753238 |
| Gnomad | rs61753238 |
| Varsome | rs61753238 |
| LitVar | rs61753238 |
| Map | rs61753238 |
| PheGenI | rs61753238 |
| Biobank | rs61753238 |
| 1000 genomes | rs61753238 |
| hgdp | rs61753238 |
| ensembl | rs61753238 |
| geneview | rs61753238 |
| scholar | rs61753238 |
| rs61753238 | |
| pharmgkb | rs61753238 |
| gwascentral | rs61753238 |
| openSNP | rs61753238 |
| 23andMe | rs61753238 |
| SNPshot | rs61753238 |
| SNPdbe | rs61753238 |
| MSV3d | rs61753238 |
| GWAS Ctlg | rs61753238 |
| Max Magnitude | 7 |
rs61753238, also known as Tyr40Ter or Y40X, is a mutation in the PEX7 gene on chromosome 6. The rare variant rs61753238(G) allele leads to the autosomal recessive disorder Rhizomelic chondrodysplasia punctata type 1 disorder when inherited in two copies or in compound heterozygotes.
| ClinVar | |
|---|---|
| Risk | Rs61753238(G;G) rs61753238(T;T) |
| Alt | Rs61753238(G;G) rs61753238(T;T) |
| Reference | Rs61753238(C;C) |
| Significance | Pathogenic |
| Disease | Peroxisome biogenesis disorder 9B Rhizomelic chondrodysplasia punctata type 1 PEX7-Related Disorders |
| Variation | info |
| Gene | PEX7 |
| CLNDBN | Peroxisome biogenesis disorder 9B Rhizomelic chondrodysplasia punctata type 1 PEX7-Related Disorders |
| Reversed | 0 |
| HGVS | NC_000006.11:g.137143923C>G |
| CLNSRC | OMIM Allelic Variant |
| CLNACC | RCV000008230.5, RCV000147254.3, RCV000324320.1, |
[PMID 12522768
] Identification of PEX7 as the second gene involved in Refsum disease.
